MAYZENT: payments to doctors
Payments that named MAYZENT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $4.1M
- Providers
- 5,510
- Transactions
- 46,764
- Average per transaction
- $88
The per-transaction average — $88 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 5,510 providers the average total is $745, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Novartis | $4,065,824 | 99.1% |
| Novartis Pharma AG | $37,179 | 0.9% |